Author: OurCrowd

[BioLumic in BioLumic] BioLumic’s first-to-market seed treatment tech goes commercial in USA

Jun 9, 2025 |

Business Desk profiles BioLumic’s leap from R&D to its first commercial contract in the United States. Field-trialed on 6,000 Midwest plots, light-activated hybrid corn averaged a 7.3% yield lift, with some second-generation plots hitting 77%. Partnering with US seed producer Gro Alliance, BioLumic is now selling light-activated seed at scale while moving its Light Recipe platform into ryegrass for New Zealand dairy, backed by fresh funding from Fonterra’s Ki Tua Fund and AgriZeroNZ. Read more...

Read More

[Stellar Cyber in BusinessWire] Stellar Cyber positioned in the Challenger Quadrant of the Gartner Magic Quadrant for Network Detection and Response

Jun 9, 2025 |

SAN JOSE, Calif.–(BUSINESS WIRE)–Stellar Cyber, the cybersecurity illumination company, today announced that The Software Report has named it one of the Top AI Companies of 2025. Stellar Cyber landed at number 14 on the annual list of the 25 most influential companies in the field of artificial intelligence, ranked alongside such high-growth companies as Anthropic, Glean, and Linksquares. Stellar Cyber is the only cybersecurity company to make the list. In addition, Stellar Cyber Founder and Chief Technical Officer Aimei Wei was named to The Software Report’s Top 25 AI Executives of 2025, recognizing her innovations and contributions to the advancement of AI in the cybersecurity industry. Read more...

Read More

[Sequentify in PR Newswire] Sequentify and Bio Molecular Systems partner to release InfiniSeq™ Myra Protocol for Automated NGS Library Preparation

Jun 9, 2025 |

The Hematology Laboratory, Molecular Hematology Unit, at Sheba Medical Center, Israel’s largest medical center, is conducting a joint study utilizing Sequentify’s InfiniSeq™ Myeloid Malignancies Panel. This study involves leading clinicians from the Cancer Center Institute, Maccabi Healthcare Services, and Sheba Cancer Research Center, focusing on identifying Clonal Hematopoiesis of Indeterminate Potential (CHIP) in patients previously diagnosed with solid tumors. The results from this study aim to advance personalized medicine in oncology, potentially influencing future patient care protocols. Read more...

Read More

[Freightos in PR Newswire] Freightos looks to scale platform transactions with Forward Air Corporation partnership

Jun 9, 2025 |

GREENEVILLE, Tenn. and BARCELONA, Spain, June 9, 2025 /PRNewswire/ — Freightos (Nasdaq: CRGO), the leading digital freight booking and payment platform, and Forward Air Corporation (Nasdaq: FWRD), known as Forward, a premier provider of ground transportation services across the United States, Canada and Mexico today announced an expanded collaboration that will enable freight forwarders to instantly book less-than-truckload (LTL) and linehaul trucking through the 7LFreight by WebCargo platform. Read...

Read More

[Anthropic in TechCrunch] Anthropic unveils custom AI models for US national security customers

Jun 5, 2025 |

Anthropic says it has released a new set of AI models tailored for U.S. national security customers. The new models, a custom set of “Claude Gov” models, were “built based on direct feedback from our government customers to address real-world operational needs,” writes Anthropic in the blog post. Compared to Anthropic’s consumer- and enterprise-focused models, the new custom Claude Gov models were designed to be applied to government operations like strategic planning, operational support, and intelligence analysis. Read...

Read More